|
|
Title | Creator | Relation Is Part Of |
51 |
|
MEK Inhibitor Treatment Promotes Retinal Ganglion Cell Preservation without Preventing Retrobulbar Demyelination in Neurofibromatosis Mice | Steven Stasheff; Francisco Nadal-Nicolas; Wei Li; Miriam Bornhorst; Yuan Zhu | NANOS 2019: Scientific Platform III |
52 |
|
Pathological Processes of Eye Muscles (Video) | Stacy Pineles, MD, MS | NANOS Annual Meeting 2015 Mechanical Causes of Strabismum |
53 |
|
Teprotumumab Efficacy in Retreatment and Longer-Term Thyroid Eye Disease: OPTIC-X Study Results | Raymond S, Douglas; Saba Sile; Terry J. Smith; George J. Kahaly | NANOS Annual Meeting 2021: Scientific Platform I |
54 |
|
VRDN-001, a Full Antagonist Antibody to IGF-1 Receptor for Thyroid Eye Disease (TED): Phase 1/2 Clinical Study in Patients | Raymond Douglas; Kimberley Cockerham; Roger Turbin; Rosa Tang; Navdeep Nijhawan Shoaib Ugradar; Denis O'Shaughnessy; Rochelle Summerfelt; Angela She; Barrett Katz | NANOS Annual Meeting 2023: Scientific Platform Session II: https://novel.utah.edu/collection/NAM/toc/ |
55 |
|
Epigenetic Reprogramming- A Novel Gene Therapy to Rejuvenate Injury-Induced Dysfunction of Retinal Ganglion Cells in Optic Neuropathies | Drenushe Krasniqi; Madhura Shah; Margarete Karg; Yuancheng Lu; David Sinclair; Bruce Ksander; Joseph Rizzo | NANOS Annual Meeting 2023: Scientific Platform Session II: https://novel.utah.edu/collection/NAM/toc/ |
56 |
|
Genotype-Phenotype Correlations in Autosomal Dominant Optic Atrophy | Joshua Harvey; Eun Hee Hong; Gerard Smits; Neringa Jerkute; Gavin Arno; Victoria Nesbitt; Marcela Votruba; Patrick Yu-Wai-Man | NANOS Annual Meeting 2022: Scientific Platform III |
57 |
|
Increase ER Stress in Ischemic Optic Neuropathy: Implications in Diabetes and Effects of Insulin Treatment | Yaping Joyce Liao; Varun Kumar; Louise Mesentier Louro; Kathleen Heng; Mohammed Shariati; Angela Oh | NANOS Annual Meeting 2018: Scientific Platform Presentations Session 2 |
58 |
|
Resveratrol Nanoparticles Are Neuroprotective in Experimental, Optic Neuritis (Video) | Ehtesham Shamsher; Reas Khan; Kimberly Dine; Vy Luong; Benjamin Davis; Keirnan Willett; Satyanarayana Somavarapu; M. Francesca Cordeiro; Kenneth Shindler | NANOS Annual Meeting 2020: Scientific Platform Session I |
59 |
|
Efficacy and Safety of Satralizumab from Two Phase 3 Trials in Neuromyelitis Optica Spectrum Disorder (Video) | Benjamin Frishberg; Jerome de Seze; Brian Weinshenker; Yusuke Terada; Yuichi Kawata; Athos Gianella-Borradori; H. Christian von Büdingen; Gaelle Klingelschmitt; Anthony Traboulsee; Takashi Yamamura | NANOS Annual Meeting 2020: Scientific Platform Session I |
60 |
|
European Perspective - It Could Be MS | Axel Petzold, MD, PhD, FRCP, FRCPath, FRCOphth | NANOS Annual Meeting 2023: State of the Art - Global Perspectives: https://novel.utah.edu/collection/NAM/toc/ |
61 |
|
NMO: What You Need to Know (Video) | Sashank Prasad | NANOS Annual Meeting 2016: Hot Topics - Today and Tomorrow |
62 |
|
Teprotumumab Effect on Proptosis, Diplopia and Quality of Life in Active Thyroid Eye Disease (TED) (Video) | Jade Schiffman; Rosa Tang; George Kahaly; Terry Smith; Saba Sile; Elizabeth Thompson; Thomas Vescio; Jeffrey Sherman; Raymond Douglas | NANOS Annual Meeting 2020: Scientific Platform Session I |
63 |
|
Visual Snow Syndrome: Differential Diagnosis and Workup | Michael Vaphiades, DO | NANOS Annual Meeting 2023: Hot Topics: https://novel.utah.edu/collection/NAM/toc/ |
64 |
|
When to Suspect a Hereditary Condition? | Dan Milea, MD, PhD | NANOS Annual Meeting 2023: Neuro-Ophthalmic Genetics: When, How, In Whom, and Why to do Genetic Testing: https://novel.utah.edu/collection/NAM/toc/ |
65 |
|
The Diversity Benefit - NANOS Diversity Report (Telehealth: A Potential Solution to the Workforce and Diversity Problem or Not?) | Kevin E. Lai, MD | NANOS Annual Meeting 2023: The Future of NO - Diversity, Equity, and Inclusion: https://novel.utah.edu/collection/NAM/toc/ |
66 |
|
Efficacy of Chronic Immunotherapy for Myelin Oligodendrocyte Glycoprotein-IgG Disease | John Chen; Collin McClelland; Eric Eggenberger; Alfonso Lopez Chiriboga; Victoria Pelak; Heather Moss; Aubrey Gilbert; Michael Lee; Marie Acierno; Muhammad Bhatti; Jiraporn Jitprapaikulsan; Gregory Van Stavern; Divyanshu Dubey; Andrew McKeon; Jeffrey Bennett; Sean Pittock; Eoin Flanagan; Ore-ofe Ade... | NANOS 2019: Scientific Platform III |
67 |
|
What is Glaucoma: Clinically, Functionally, and Pathologically? (Video) | Carol A. Rasmussen, MS; Paul L. Kaufman, MD | |
68 |
|
Acute Therapeutic Options for CRAO: To TPA or Not? | Oana M. Dumitrascu, MD, MS | NANOS Annual Meeting 2023: Hot Topics: https://novel.utah.edu/collection/NAM/toc/ |
69 |
|
International Multicenter Retrospective Study on Maintenance Intravenous Immunoglobulin in Preventing Relapse in Adult MOG-Antibody-Associated Disease | John Chen; Saif Huda; Yael Hacohen; Michael Levy; Itay Lotan; Adi Wilf-Yarkoni; Hadas Stiebel-Kalish; Mark Hellmann; Elias Sotirchos; Amanda Henderson; Sean Pittock; M. Tariq Bhatti; Eric Eggenberger; Marie DiNome; Ho Jin Kim; Albert Saiz; Friedemann Paul; Russell Dale; Sudarshini Ramanathan; Jacque... | NANOS Annual Meeting 2022: Scientific Platform Session II |
70 |
|
Pathogenic NR2F1 Variants Cause a Systemic Neurodevelopmental Ocular Phenotype Recapitulated in a Mutant Mouse Model | Neringa Jurkute; Michele Bertacchi; Gavin Arno; Chiara Tocco; Ungsoo Kim; Adam Kruszewski; Robert Avery; Emma Bedoukian; Jinu Han; Sung Ahn; James Acheson; Indran Davagnanam; Richard Bowman; Marios Kaliakatsos; Ashwin Reddy; Ngozi Oluonye; Patrizia Amati-Bonneau; Majida Charif; Guy Lenaers; Isabelle... | NANOS Annual Meeting 2021: Scientific Platform I |
71 |
|
NMO or NOT NMO, That Is the Question | Carolyne Riehle, Emily Spoth, Jill Wilson, Bradley Katz, Meagan Seay, Sravanthi Vegunta, Judith Warner, Kathleen Digre | NANOS Annual Meeting 2023: Walsh Society Meeting Session I: "Adventureland": Learning From Pediatric Neuro-Ophthalmic Disorders: https://novel.utah.edu/collection/NAM/toc/ |